Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

Cancer Prevention Research

Volumn 1, Issue 3, 2008, Pages 216-

  Lance, Peter ^a   Hamilton, Stanley R ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58349107214     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0132     Document Type: Letter

References (5)

1. Lance P, Hamilton SR. Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention. Cancer Prev Res 2008;1:4-8 (access via http://cancerpreventionresearch.aacrjournals.org/cgi/reprint/1/1/4).
2. Cho NL, Redston M, Zauber AG, et al. Aberrant crypt foci in the Adenoma Prevention with Celecoxib trial. Cancer Prev Res 2008;1:21-31 (access via http://cancerpreventionresearch.aacrjournals.org/cgi/reprint/1/1/21).
3. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37: 147-51.
4. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-7.
5. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339:1277-84.